You are here

  • Home
  • Online First
  • Alpha-2 antagonists should be developed as xylazine antidotes in humans

Article Text

Article menu
Download PDFPDF
Letter
Alpha-2 antagonists should be developed as xylazine antidotes in humans

https://doi.org/10.1136/rapm-2024-105471

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    You do not have access to the full text of this article, the first page of the PDF of this article appears above.

    Footnotes

    • Conflict of interest: Alexander Stone is an associate editor at Regional Anesthesia Pain Medicine.

    • X @alexbstone

    • Contributors WO: study design manuscript preparation and review. JOA: study design manuscript preparation and review. ABS: study design manuscript preparation and review.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.